Lexaria Bioscience Corp Stock Probability of Future Stock Price Finishing Under 2.21
| LEXX Stock | USD 2.37 0.16 7.24% |
Lexaria |
Lexaria Bioscience Target Price Odds to finish below 2.21
The tendency of Lexaria Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 2.21 or more in 90 days |
| 2.37 | 90 days | 2.21 | about 20.52 |
Based on a normal probability distribution, the odds of Lexaria Bioscience to drop to $ 2.21 or more in 90 days from now is about 20.52 (This Lexaria Bioscience Corp probability density function shows the probability of Lexaria Stock to fall within a particular range of prices over 90 days) . Probability of Lexaria Bioscience Corp price to stay between $ 2.21 and its current price of $2.37 at the end of the 90-day period is about 13.48 .
Given the investment horizon of 90 days Lexaria Bioscience has a beta of 0.16. This indicates as returns on the market go up, Lexaria Bioscience average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Lexaria Bioscience Corp will be expected to be much smaller as well. Additionally Lexaria Bioscience Corp has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Lexaria Bioscience Price Density |
| Price |
Predictive Modules for Lexaria Bioscience
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Lexaria Bioscience Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lexaria Bioscience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lexaria Bioscience Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Lexaria Bioscience is not an exception. The market had few large corrections towards the Lexaria Bioscience's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Lexaria Bioscience Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Lexaria Bioscience within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.47 | |
β | Beta against Dow Jones | 0.16 | |
σ | Overall volatility | 0.39 | |
Ir | Information ratio | -0.12 |
Lexaria Bioscience Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Lexaria Bioscience for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Lexaria Bioscience Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Lexaria Bioscience generated a negative expected return over the last 90 days | |
| Lexaria Bioscience has high historical volatility and very poor performance | |
| Lexaria Bioscience has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 464.28 K. Net Loss for the year was (5.81 M) with profit before overhead, payroll, taxes, and interest of 183.56 K. | |
| Lexaria Bioscience Corp currently holds about 7.34 M in cash with (4.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.23. | |
| Lexaria Bioscience has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Disposition of 200000 shares by Richard Christopher of Lexaria Bioscience at 3.92 subject to Rule 16b-3 |
Lexaria Bioscience Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Lexaria Stock often depends not only on the future outlook of the current and potential Lexaria Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lexaria Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 12.4 M | |
| Cash And Short Term Investments | 6.6 M |
Lexaria Bioscience Technical Analysis
Lexaria Bioscience's future price can be derived by breaking down and analyzing its technical indicators over time. Lexaria Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Lexaria Bioscience Corp. In general, you should focus on analyzing Lexaria Stock price patterns and their correlations with different microeconomic environments and drivers.
Lexaria Bioscience Predictive Forecast Models
Lexaria Bioscience's time-series forecasting models is one of many Lexaria Bioscience's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Lexaria Bioscience's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Lexaria Bioscience Corp
Checking the ongoing alerts about Lexaria Bioscience for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Lexaria Bioscience Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Lexaria Bioscience generated a negative expected return over the last 90 days | |
| Lexaria Bioscience has high historical volatility and very poor performance | |
| Lexaria Bioscience has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 464.28 K. Net Loss for the year was (5.81 M) with profit before overhead, payroll, taxes, and interest of 183.56 K. | |
| Lexaria Bioscience Corp currently holds about 7.34 M in cash with (4.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.23. | |
| Lexaria Bioscience has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Disposition of 200000 shares by Richard Christopher of Lexaria Bioscience at 3.92 subject to Rule 16b-3 |
Additional Tools for Lexaria Stock Analysis
When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.